相关实验视频

Updated: Apr 12, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

克罗塔拉利亚麦杜伦西斯 (Crotalaria madurensis) 的黄醇糖化物的抗菌活性对抗金黄色葡萄球菌 (Staphylococcus aureus)

Hala Sh Mohammed¹, Salwa A Abu El Wafa¹, Mona H Ibrahim²

¹Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.

|November 4, 2024

概括

克罗塔拉里亚麦杜伦西斯提取物及其代谢物1显示强烈的抗氧化和抗菌活性对抗抗甲素耐药黄金葡萄球菌 (MRSA). 马辐射并没有减轻这些影响,这表明MRSA感染的自然治疗方法稳定有效.

科学领域:

植物化学植物化学
自然产品化学化学
抗菌研究抗菌研究

背景情况:

耐甲基西林黄金葡萄球菌 (MRSA) 在医疗保健环境中构成重大威胁,需要新的治疗策略.
天然产品为开发新抗菌剂对抗耐药细菌菌株提供了有希望的途径.

研究的目的:

为了研究Crotalaria madurensis的化学成分,空中部分.
评估植物提取物及其分离代谢物对MRSA的抗氧化和抗菌特性.
评估玛辐射对提取物和关键代谢物的抗菌疗效的影响.

主要方法:

植物化学分析,包括里埃变换红外光谱 (FTIR) 分析,以识别分离的化合物.
在体外抗氧化剂测试以确定激素清除活性.
抗菌测试以评估MRSA活力和细胞数量的减少.
分子对接研究,以预测结合亲和力和相互作用.

主要成果:

确定了四种黄醇糖化物,其中gossypetin 8-methoxy,3-O-β-D-xylopyranoside (代谢物1) 显示出显著的抗氧化和抗菌活性.
植物提取物和代谢物1在测试度下有效降低了MRSA活力和细胞数量.
50和100 Gy的马辐射并没有显著改变提取物和代谢物1的抗菌特性.
在FTIR分析中,治疗后MRSA过物的特性发生了显著的变化.
分子对接表明代谢物1对目标分子具有强烈的结合亲和力,预测了高的抗氧化和抗MRSA潜力.

结论:

克罗塔拉利亚麦杜伦斯是一种强大的抗氧化和抗菌化合物的来源,特别是代谢物1.
代谢物1显示出作为治疗MRSA感染的治疗剂的巨大潜力.
玛辐射后抗菌活性的稳定性表明,它对于潜在的配方和应用具有强度.

关键词:

这是一种Crotalaria madurensis.抗菌剂抗菌剂抗菌剂抗氧化剂是一种抗氧化剂.停靠研究对接研究这是一种黄醇 (flavonol).在MRSA中,MRSA可能是MRSA.

更多相关视频

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

相关概念视频

Staphylococcal Skin Infections

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...